MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202418019985 A) filed by Bioverativ Therapeutics Inc. on March 18, 2024, for Isolated Nucleic Acid Molecule.
Inventors include Tan,siyuan; and Liu,tongyao.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: An isolated nucleic acid molecule comprising a nucleotide sequence encoding a polypeptide with FVIIl activity, wherein the nucleotide sequence has: at least 91%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to nucleotides 58-2277 and 98%, at least ID NO: at least 2320-4374 of SEQ ID NO: 1; at least 94%, at least 95%, at least 96%, at least 97%, or at least 99% sequence identity to nucleotides 58-2277 and 2320-4374 of SEQ 2; at least 90%, at least 91%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to nucleotides 58-2277 and 2320-4374 of SEQ ID NO: 70; (iv) about 92%, at least about 93%, at least about 94%, at least about 95%, at least 96%, at least 97%, at least 98% or at least 99% sequence identity to nucleotides 58-2277 and 2320- 4374 of ID NO: 3; (v)at least about 91%, at least about 92%, at least about 93%, at least about at least about 95%, at least 96%, at least 97%, at least 98% or at least 99% sequence identity to nucleotides 58-2277 and 2320-4374 of SEQ ID NO: 4; (vi) at least 90%, 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least or at least 99% sequence identity to nucleotides 58-2277 and 2320-4374 of SEQ ID NO: 5; or (vii) at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at SEQ 94%, 98%, at least least 96%, at least 97%, at least 98%, or at least 99% sequence identity to nucleotides 58-2277 and 2320-4374 of SEQ ID NO: 6.
Disclaimer: Curated by HT Syndication.
